Needle therapy shows promise for whiplash arm pain
NCT ID NCT06086899
First seen Jun 26, 2026 · Last updated Aug 18, 2026 · Updated 3 times
Summary
This study tested a special acupuncture technique called motion style acupuncture treatment (MSAT) for people with radiating arm pain after a traffic accident. 100 adults aged 19-69 who were hospitalized with pain starting within 3 days of the accident took part. The treatment involves moving the painful area while needles are in place. The goal was to see if MSAT reduces pain better than standard Korean medicine.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- motion style acupuncture treatment (MSAT)
- What this could lead to
- If it works, this could offer a non-drug option for quickly easing radiating arm pain after a car accident.
- What could go wrong
- This is a small, completed trial with 100 people. Results may not apply to everyone, and the effect might be modest or no better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 19-69 years on the date they sign the consent form. * Patients who are suffered byradiating pain in the upper extremity that occurred within 3 days after traffic accident. * Patients who are hospitalized due to traffic accident. * Patients with NRS of radiating pain ≥ 5. * Patients who provide consent to participate in the trial and return the informed consent form. Exclusion Criteria: * Patients with a specific serious disease that may cause radiating pain: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients with progressive neurological deficits or with severe neurological symptoms. * Patients with medical history of cervical surgery or thoracic surgery within the last three weeks. * Patients who have radiating pain in upper extremity before the traffic accident. * Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc. * Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study. * If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease. * Patients who are pregnant or planning to become pregnant. * Patients who are participated in clinical trials other than observational studies without therapeutic intervention. * Patients who are difficult to complete the research participation agreement. * Other patients whose participation in the trial is judged by a researcher to be problematic.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Radiating pain in the upper extremity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea